Good evening :)
Switch to
Place Order

Aurobindo Pharma Ltd

AUROPHARMA
Health CarePharmaceuticals
MidcapWith a market cap of ₹42,975 cr, stock is ranked 115
Low RiskStock is 2.00x as volatile as Nifty
721.5511.90 (-1.62%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
MidcapWith a market cap of ₹42,975 cr, stock is ranked 115
Low RiskStock is 2.00x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
8.06
PB RatioPB Ratio
1.96
Dividend YieldDiv. Yield
0.55%
Sector PESector PE
40.52
Sector PBSector PB
5.42
Sector Div YldSctr Div Yld
0.63%

Forecast & RatingsDetailed Forecast 

81%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Aurobindo Pharma Limited is a pharmaceutical company. The Company is engaged in producing oral and injectable generic formulations and active pharmaceutical ingredients (APIs).

Brands

Aurobindo Pharma

Pharmaceutical company

Investor PresentationView older 

Aug 12, 2021

PDF
View Older Presentations

Brands

Aurobindo Pharma

Pharmaceutical company

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

201820192020202116.5719.7223.2928.402.422.362.855.33
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Press Release 
Announced OnSep 22, 2021

Aurobindo Pharma Limited has informed the Exchange regarding a press release dated September 22, 2021, titled "Submission of first biosimilar filing with EMA". | Download

Aurobindo Pharma Limited has informed the Exchange regarding a press release dated September 22, 2021, titled "Submission of first biosimilar filing with EMA". | Download

Analysts/Institutional Investor Meet/Con. Call Updates 
Announced OnSep 20, 2021

Aurobindo Pharma Limited has informed the Exchange about Analysts/Institutional Investor Meet/Con. Call Updates | Download

Aurobindo Pharma Limited has informed the Exchange about Analysts/Institutional Investor Meet/Con. Call Updates | Download

Cash Dividend 
Ex. DateAug 27, 2021

Interim • Div/Share: ₹ 1.5

See all events